E. Cerbai et al., Modulation of the pacemaker current I-f by beta-adrenoceptor subtypes in ventricular myocytes isolated from hypertensive and normotensive rats, CARDIO RES, 42(1), 1999, pp. 121-129
Citations number
43
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Objective: Both beta(1)- and beta(2)-adrenoceptors (beta(1)-AR and beta(2)-
AR) are functionally present in human and rat ventricular myocytes. The two
receptor subtypes are differently regulated during the development of myoc
ardial hypertrophy and failure. I-f is expressed in human and rat ventricul
ar myocytes. In hypertrophied myocytes isolated from old spontaneously hype
rtensive rats (SHR) the density is much larger than in age-matched normoten
sive Wistar Kyoto (WKY). Due to the possible relevance of I-f as an arrhyth
mogenic mechanism in the rat and human ventricle, we studied and compared t
he effects of beta(1)-AR and beta(2)-AR stimulation on I-f in both hypertro
phied and normal left ventricular myocytes of 18-month old SHR and WKY. Met
hods: The whole-cell configuration of the patch-clamp technique was employe
d. Noradrenaline (NA, 1 mu M) was used to stimulate beta(1)-AR and isoprena
line (LSO, 1 mu M) in the presence of the beta(1)-AR antagonist CGP 20712A
(0.1 mu M) to stimulate beta(2)-AR. Results: In SHR, NA increased I-f by ca
using a 10.8+/-0.9 mV(n = 10)positive shift in the voltage of maximal activ
ation (V-1/2); this effect was completely reversed by CGP 20712A. beta(2)-A
R stimulation was effective in seven out of 13 cells tested, where it cause
d a small positive shift in V-1/2 (4.0+/-1.7 mV). Cyclopentyladenosine (CPA
), a selective A(1)-receptor agonist, reversed the effect of NA; the antiad
renergic action of CPA was abolished in cells pre-incubated with pertussis
toxin (PTX) to block inhibitory G proteins (Gi). In PTX-treated cells the s
hift in V-1/2 caused by both beta(2)-AR (9.6+/-1.7 mV, n=6, p<0.05) and bet
a(1)-AR (17.6+/-1.9 mV, n=7, p<0.05) was significantly greater than in cont
rol cells. Both beta-AR subtypes modulated I-f activation also in WKY: beta
(1)-AR shifted V-1/2 by 16.0+/-1.4 mV (n=15) and beta(2)-AR by 4.2+/-1.1 mV
(n=7). However, in PTX-treated WKY cells only the beta(2)-AR effect was po
tentiated (shift in V-1/2: 11.4+/-1.4 mV, n=9, p<0.01), while the beta(1)-A
R response was unchanged (18.9+/-4.2 mV, n=5, n.s.). Condusions: I-f expres
sed in SHR hypertrophied ventricular myocytes is modulated by catecholamine
s mainly through the stimulation of the beta(1)-AR subtype. The beta(1)-AR
response is, however, significantly lower than that observed in myocytes fr
om normotensive rats, probably as a consequence of the presence of an incre
ased inhibitory activity of Gi proteins. This post-receptorial control may
be seen as a mechanism to limit the arrhythmogenicity of beta-AR stimulatio
n in myocardial hypertrophy and failure. (C) 1999 Elsevier Science B.V. All
rights reserved.